The eight “Dogs of the Dow” for 2019 had an aggregate year-to-date gain of 10.7% in March, up from 8.8% at the end of February led by a gain of 24.6% for Cisco Systems, 24.1% for IBM and 18.5% for ExxonMobil. The Dow Jones Industrial Average ended March with a year-to-date gain of 11.2%, up slightly from 11.1% at the end of February.
Buy weakness to my semiannual and annual value levels of $41.70 and $39.84, respectively, and reduce holdings on strength to my monthly risky level at $55.58. My quarterly pivot is $52.67.
Chevron (CVX) ended March with a dividend yield of 3.93%, down from 4.27% in December, ranked fourth. The weekly chart for Chevron is positive but overbought with the stock above its five-week MMA at $121.77 and above its 200-week SMA or reversion to the mean at $107.81. The 12x3x3 weekly slow stochastic reading is above the overbought threshold of 80.00 at 85.61.
Buy weakness to my monthly and semiannual value levels of $109.44 and $106.15, respectively, and reduce holdings on strength to my quarterly and annual risky levels at $129.28 and $131.43, respectively.
International Business Machines (IBM) ended March with a dividend yield of 4.65%, down from 5.71% in December, still ranked first. The weekly chart for IBM is positive but overbought with the stock above its five-week MMA at $137.81 but below its 200-week SMA or reversion to the mean at $149.23. The 12x3x3 weekly slow stochastic reading is projected to rise to 93.45 this week as an inflating parabolic bubble.
Buy weakness to my semiannual, monthly and quarterly value levels at $126.75, $123.03 and $113.89, respectively, and reduce holdings on strength to my annual risky level at $166.09.
JPMorgan Chase (JPM) ended March with a dividend yield of 3.50%, up from 3.45% in December, now ranked fifth. The weekly chart for our nation’s largest bank is neutral with the stock above its five-week MMA at $103.04 and above its 200-week SMA or reversion to the mean at $86.81. The 12x3x3 weekly slow stochastic reading is projected to decline to 55.29 this week.
Buy weakness to my monthly value level at $97.40 and reduce holdings strength to my semiannual and quarterly risky levels at $110.75 and $116.81, respectively. My annual pivot remains at $102.64.
Coca Cola (KO) ended March with a dividend yield of 3.44%, down from 3.46% in December, now ranked seventh. The weekly chart for Coke is positive with the stock above its five-week MMA at $46.40 and above its 200-week SMA or reversion to the mean at $44.10. The 12x3x3 weekly slow stochastic reading is projected to rise to 27.85 this week.
Buy weakness to the 200-week SMA at $44.10 and reduce holdings on strength to monthly, quarterly and annual at $47.50, $48.74 and $51.51, respectively. My semiannual pivot at $46.28 is a magnet.
Pfizer (PFE) ended March with a dividend yield of 3.44%, up from 3.30% in December, now ranked sixth. The weekly chart for Pfizer is positive with the stock above its five-week MMA at $42.35. The stock is well above its 200-week SMA or reversion to the mean at $35.59. The 12x3x3 weekly slow stochastic reading is projected to rise to 56.74 this week.
Buy weakness to my semiannual value level at $41.49 and reduce holdings on strength to my monthly and annual risky levels at $46.57 and $48.44, respectively. My quarterly pivot is $43.55.
Verizon (VZ) ended March with a dividend yield of 4.12%, down from 4.31% in December, ranked third. The weekly chart for Verizon is positive with the stock above its five-week MMA at $57.94. The stock is above its 200-week SMA or reversion to the mean at $50.38. The 12x3x3 weekly slow stochastic reading is projected to rise to 77.71 this week.
Buy weakness to my quarterly and semiannual value levels at $56.38 and $55.97, respectively, and reduce holdings on strength to my monthly and annual risky levels at $62.05 and $62.95, respectively.
ExxonMobil (XOM) ended March with a dividend yield of 4.31%, down from 5.03% in December, ranked second. The weekly chart for Exxon is positive but overbought with the stock above its five-week MMA at $79.18 and testing its 200-week SMA or reversion to the mean at $81.66. The 12x3x3 weekly slow stochastic reading is projected to rise to 88.42 this week above the overbought threshold of 80.00.
Buy weakness to my monthly, semiannual and quarterly value levels at $75.48, $69.47 and $77.66, respectively, and reduce holdings on strength to my annual risky level at $94.26.